Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

MediXall (MDXL) Total Current Liabilities (2019 - 2024)

MediXall's Total Current Liabilities history spans 8 years, with the latest figure at $3.8 million for Q3 2024.

  • For Q3 2024, Total Current Liabilities fell 33.51% year-over-year to $3.8 million; the TTM value through Sep 2024 reached $3.8 million, down 33.51%, while the annual FY2023 figure was $6.7 million, 54.27% up from the prior year.
  • Total Current Liabilities reached $3.8 million in Q3 2024 per MDXL's latest filing, down from $7.7 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $7.7 million in Q2 2024 to a low of $710160.0 in Q2 2021.
  • Average Total Current Liabilities over 5 years is $3.6 million, with a median of $3.7 million recorded in 2022.
  • Peak YoY movement for Total Current Liabilities: skyrocketed 304.07% in 2023, then plummeted 33.51% in 2024.
  • A 5-year view of Total Current Liabilities shows it stood at $1.1 million in 2020, then grew by 9.29% to $1.2 million in 2021, then surged by 254.35% to $4.3 million in 2022, then surged by 54.27% to $6.7 million in 2023, then plummeted by 43.37% to $3.8 million in 2024.
  • Per Business Quant, the three most recent readings for MDXL's Total Current Liabilities are $3.8 million (Q3 2024), $7.7 million (Q2 2024), and $7.2 million (Q1 2024).